Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ... Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

library.whnlive.com
from library.whnlive.com More from this publisher
12.07.2015 Views

494only about 500 or 600 ])eople on it, suggests that it has low acceptance.At least, it is not something that people will come to.Mr. Brasco. So, \\'hat you are basically talking about, is not somuch the bad side effects but theie is not enough work done on it?Dr. ViLLARREAL. Well, there are bad side effects.Mr. Brasco. There are bad side effects.Dr. ViLLARREAL. The bad side effects can be dealt with effectivelyb}' slow increases in dose. Dr. Resnick is more competent to answerthis question with regard to humans.Mr. Brasco. All right. We will ask that of Dr. Resnick.Thank you.Dr. ViLLARREAL. 1 woulil like to say one last thing. The fact thatwe have the animal models of human dependence has opened up thepossibilit}" for the j'esearch on other drugs that will block self-administrationof narcotics, not just the narcotic antagonists.Mr. Perito. Are such tlrugs within our (•aj)abiHty of developnx'ut?Dr. ViLLARREAL. Well, this is more remote. The antagonists—wealready have quite a few, as you know. It is just a question of development.There is no more research that has to be done. The question isto have effective delivery methods of keeping up concentrations in theblood and tissues for long periods of time.Ml". Perito. You mean you know the basic concept of an antagonist.What you need to Jo is develo]) one that has a longer diu-ationof action. Is that what yen are saying?Dr. ViLLARREAL. That is right. We have a whole lot of very potentdrugs on the shelf.Mr. Perito. What is the reason we have not developed this?Dr. ViLLARREAL. There have been ver}^ few people who havethought about it. Leadership has been missing. Dr. Martin had beenbehind it. A group of doctors, mainly Freedman and Fink, have beenpushing it but there have been very few isolated instances of humanresearch.Chairman Pepper. Doctor, have the efforts to develop some of thesedifferent drugs, blockage drugs and immunizing drugs, have thoseeff'orts been impeded b}' lack of funds?Dr. ViLLARREAL. They have not been encouraged.Chairman Pepper. Well, now, you are at a university. You evidentlyare a verv great leader in this field. Have you had adequatefinancing foi the programs upon which you are working?Dr. ViLLARREAL. We do not have specific financing for the developmentof antidependence drugs. Our research is funded on the basis ofthe work we do for developing analgesics. We have done the antidependenceresearch on the side.Chairman Pepper. Do you think if the Federal Government,through an appropriate agency, after a proper screening process,made funds available for the development of leads that scientistshave uncovered, that we could make a great (h>al of progress towardfinding the necessary drugs to treat these addictions?Dr. ViLLARREAL. I would ihiuk that would be indispensable to makeserious progress along these lines, eillicr formalizing and organizingthe isolated efforts of different indivicknds or by making contracts tospecific drug firms to th'veloj) compouutls along the lines we havediscussed.

495Chairman Pepper. One other question. Is there a reservoir of talentin the coUeges and universities of the coiuitry that coukl be devoted tosuch objectives as these if tliey were adequately financed andencouraged?Dr. ViLLARREAL. Yes; there would have to be a great deal of leadershipand organization centrally to see what people could do and perhapsa committee of the peoi)le that have already done work in thisfield could organize something along the lines you suggest.Chairman Pepper. Now, would it be desirable, Doctor, if you had aFederal agency that could not only make funds available and assist inscreening in collaboration with the scientific community the proposalsthat were made but could coordinate as among Federal, State, andother agencies, the drug industry, and the colleges and universities ofthe country, a massive research program toward these objectives?Dr. ViLLARREAL. Ycs, it would be very highly desu'able. There isjust one factor universities do not have. They do not have the knowhowand the wide experience that industry has in certain stages ofdevelopment. The studies of toxicology, the j)harmaceutical formulations,the red tape to get the clinical trials, and so on.Chamnan Pepper. I have also been told—I would like to ask youif you think there is any truth in this— that one reason the universitiesare reluctant to get into these areas is because these men are valuablemen and there are many demands upon their time and at the sametime, they have to think about continuity of their own employment.So, if they are pulled off of a program that seems to have permanenceand put on a program which is only temporary in character, which mayterminate at an early date, it is more difficult to get these good men togive continuity to such programs; is it not?Dr. ViLLARREAL. Well, that is right, but that is a generalized problemfor all research. I would note, though, that there are some precedentsin the antimalarial drug research programs that were carriedout in universities during the war and also the anticancer program ofthe National Institutes of Health.Chairman Pepper. Do you have any questions, Mr. Blommer?Mr. Blommer. One question, Doctor. I have talked to a man whowas a drug addict and was sent to Dannemora Prison for 6 yearswithout any drugs. When he got out of prison he got on the train goingback to New York City. He got 30 miles from New York City andstarted going into withdrawal symptoms and he was vomiting.Now, at the point that that man physically had withdrawal symptoms,would you say he was suffering from a mental problem or aphysical problem, or both?Dr. ViLLARREAL. WcU, both. That is, the impulse to take the drugis a physical thing as well as a psychological thing, if you want. Thatis, the main point is that the drug users do not reason, well, I amgoing to have a drug, and go through a syllogism and a formal reasoning.It is something that occurs to them. They find themselves lookingfor the drug. It is like the alcoholic who drinks or is looking in hispocket for the money. He finds he is an alcoholic when he is spending$15 a week on whisky, but not before.These are not rational decisions made. These are things thathappen. The addict finds that you have this impulse to take the drug.

495Chairman Pepper. One other question. Is there a reservoir of talentin the coUeges <strong>and</strong> universities of the coiuitry that coukl be devoted tosuch objectives as these if tliey were adequately financed <strong>and</strong>encouraged?Dr. ViLLARREAL. Yes; there would have to be a great deal of leadership<strong>and</strong> organization centrally to see what people could do <strong>and</strong> perhapsa committee of the peoi)le that have already done work in thisfield could organize something along the lines you suggest.Chairman Pepper. Now, would it be desirable, Doctor, if you had aFederal agency that could not only make funds available <strong>and</strong> assist inscreening in collaboration with the scientific community the proposalsthat were made but could coordinate as among Federal, State, <strong>and</strong>other agencies, the drug industry, <strong>and</strong> the colleges <strong>and</strong> universities ofthe country, a massive <strong>research</strong> program toward these objectives?Dr. ViLLARREAL. Ycs, it would be very highly desu'able. There isjust one factor universities do not have. They do not have the knowhow<strong>and</strong> the wide experience that industry has in certain stages ofdevelopment. The studies of toxicology, the j)harmaceutical formulations,the red tape to get the clinical trials, <strong>and</strong> so on.Chamnan Pepper. I have also been told—I would like to ask youif you think there is any truth in this— that one reason the universitiesare reluctant to get into these areas is because these men are valuablemen <strong>and</strong> there are many dem<strong>and</strong>s upon their time <strong>and</strong> at the sametime, they have to think about continuity of their own employment.So, if they are pulled off of a program that seems to have permanence<strong>and</strong> put on a program which is only temporary in character, which mayterminate at an early date, it is more difficult to get these good men togive continuity to such programs; is it not?Dr. ViLLARREAL. Well, that is right, but that is a generalized problemfor all <strong>research</strong>. I would note, though, that there are some precedentsin the antimalarial drug <strong>research</strong> programs that were carriedout in universities during the war <strong>and</strong> also the anticancer program ofthe National Institutes of Health.Chairman Pepper. Do you have any questions, Mr. Blommer?Mr. Blommer. One question, Doctor. I have talked to a man whowas a drug addict <strong>and</strong> was sent to Dannemora Prison for 6 yearswithout any drugs. When he got out of prison he got on the train goingback to New York City. He got 30 miles from New York City <strong>and</strong>started going into withdrawal symptoms <strong>and</strong> he was vomiting.Now, at the point that that man physically had withdrawal symptoms,would you say he was suffering from a mental problem or aphysical problem, or both?Dr. ViLLARREAL. WcU, both. That is, the impulse to take the drugis a physical thing as well as a psychological thing, if you want. Thatis, the main point is that the drug users do not reason, well, I amgoing to have a drug, <strong>and</strong> go through a syllogism <strong>and</strong> a formal reasoning.It is something that occurs to them. They find themselves lookingfor the drug. It is like the alcoholic who drinks or is looking in hispocket for the money. He finds he is an alcoholic when he is spending$15 a week on whisky, but not before.These are not rational decisions made. These are things thathappen. The addict finds that you have this impulse to take the drug.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!